Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • PacBio

    - PMLiVE

    NHS England begins newborn screening programme to identify rare genetic conditions

    The Generation Study is aiming to screen 100,000 newborns for more than 200 diseases

    - PMLiVE

    UK national study supports whole genome sequencing in standard cancer care

    The trial combined data from the UK’s 100,000 Genomes Project and NHS records

    - PMLiVE

    Seqera Labs and Genomics England partner to progress genomic research

    The collaboration is aimed at helping more patients benefit from genomic healthcare

    - PMLiVE

    Genomics England receives government funding for cutting-edge genomics research

    £105m will be used to accelerate the diagnosis of rare genetic diseases in newborns

    - PMLiVE

    Genomics England will move headquarters to Canary Wharf’s new life sciences hub

    The company will join the growing number of healthcare and life sciences-focused organisations currently located in Canary Wharf

    - PMLiVE

    UK’s CMA fines drugmakers £260m for overcharging NHS for steroid med

    Three of the ten companies named in CMA’s statement said they disagreed with the decision and would be appealing against the fines

    - PMLiVE

    AstraZeneca clears latest hurdle for Alexion acquisition after EU clearance

    AZ first announced the proposed acquisition of Alexion in December 2020

    - PMLiVE

    UK’s Competition and Markets Authority to review AZ/Alexion merger

    Proposed acquisition has already received competitions clearance in the US and Canada

    Roche Basel Switzerland

    Roche and Illumina partner on genomics for cancer diagnostics

    Will leverage genomics system to match optimal cancer treatment

    - PMLiVE

    UK’s CMA clears Roche’s $4.3bn takeover of Spark

    Roche first announced deal in February

    - PMLiVE

    Pfizer, Flynn face reinstatement of £90m CMA fine

    Facing penalty for dramatic price hikes of an epilepsy drug

    - PMLiVE

    UK government raises concerns about Illumina’s $1.2bn takeover of PacBio

    CMA concludes the merger will result in loss of market competition

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links